Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Notes Payables (2021 - 2026)

BioScience Health Innovations has reported Notes Payables over the past 3 years, most recently at $460402.0 for Q1 2026.

  • Quarterly Notes Payables changed N/A to $460402.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $460402.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $7050.0 for FY2021, N/A changed from the prior year.
  • Notes Payables was $460402.0 for Q1 2026 at BioScience Health Innovations, up from $7050.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $460402.0 in Q1 2026 and troughed at $7050.0 in Q1 2022.